migraine 2
TRANSCRIPT
8/14/2019 Migraine 2
http://slidepdf.com/reader/full/migraine-2 1/23
8/14/2019 Migraine 2
http://slidepdf.com/reader/full/migraine-2 2/23
8/14/2019 Migraine 2
http://slidepdf.com/reader/full/migraine-2 3/23
Common misdiagnosesCommon misdiagnoses
for migraine:for migraine:
– – Sinus HA Sinus HA
– – Stress HA Stress HA
Referral to ENT for sinusReferral to ENT for sinus
disease and facial pain.disease and facial pain.
8/14/2019 Migraine 2
http://slidepdf.com/reader/full/migraine-2 4/23
Migraineurs more likely to haveMigraineurs more likely to have
motion sickness.motion sickness.
Half of Meniere’s patients claim toHalf of Meniere’s patients claim to
have migrainous symptoms.have migrainous symptoms.
BPPVBPPV
8/14/2019 Migraine 2
http://slidepdf.com/reader/full/migraine-2 5/23
$13 billion/year in lost$13 billion/year in lost
productivityproductivity
1/3 participants in1/3 participants in American Migraine Study American Migraine Study
II missed work in prior 3II missed work in prior 3
monthsmonths
8/14/2019 Migraine 2
http://slidepdf.com/reader/full/migraine-2 6/23
Migraine DefinitionMigraine Definition
IHS criteria: Migraine/aura (3 out of 4)IHS criteria: Migraine/aura (3 out of 4)
– – One or more fully reversible auraOne or more fully reversible aurasymptoms indicates focal cerebralsymptoms indicates focal cerebral
cortical or brainstem dysfunction.cortical or brainstem dysfunction. – – At least one aura symptom At least one aura symptom
develops gradually over moredevelops gradually over morethan 4 minutes.than 4 minutes.
– – No aura symptom lasts more thanNo aura symptom lasts more thanone hour.one hour.
– – HA follows aura w/free interval of HA follows aura w/free interval of less than one hour and may beginless than one hour and may beginbefore or w/aura.
IHS Diagnostic criteria: migraine w/oIHS Diagnostic criteria: migraine w/oauraaura
– – HA lasting for 4HA lasting for 4--72 hrs72 hrs
– – HA w/2+ of following:HA w/2+ of following: UnilateralUnilateral
PulsatingPulsating
Mod/severe intensity.Mod/severe intensity.
Aggravated by routine Aggravated by routine
physical activity.physical activity. – – During HA at least 1 of followingDuring HA at least 1 of following
N/VN/V
PhotophobiaPhotophobia
Phonophobia
before or w/aura.
Phonophobia
History, PE, Neuro exam show no other organic disease.History, PE, Neuro exam show no other organic disease.
At least five attacks occur At least five attacks occur
8/14/2019 Migraine 2
http://slidepdf.com/reader/full/migraine-2 7/23
Migraine SubtypesMigraine Subtypes
Basilar type migraineBasilar type migraine – – Dysarthria, vertigo,Dysarthria, vertigo,
diplopia, tinnitus,diplopia, tinnitus,decreased hearing, ataxia,decreased hearing, ataxia,bilateral paresthesias,bilateral paresthesias,altered consciousness.altered consciousness.
– – Simultaneous bilateralSimultaneous bilateral
visual symptoms.visual symptoms. – – No muscular weakness.No muscular weakness.
Retinal or ocular migraineRetinal or ocular migraine – – Repeated monocularRepeated monocular
scotomata or blindness < 1scotomata or blindness < 1hrhr
– – Associated with or followed Associated with or followedby a HA by a HA
8/14/2019 Migraine 2
http://slidepdf.com/reader/full/migraine-2 8/23
Migraine SubtypesMigraine Subtypes
Menstrual migraineMenstrual migraine
Hemiplegic migraineHemiplegic migraine – – Unilateral motor andUnilateral motor and
sensory symptomssensory symptoms
that may persist afterthat may persist afterthe headache.the headache.
– – Complete recoverComplete recover
Familial hemiplegicFamilial hemiplegicmigrainemigraine
8/14/2019 Migraine 2
http://slidepdf.com/reader/full/migraine-2 9/23
Migrainous vertigoMigrainous vertigo
Vertigo Vertigo – – sole or prevailing symptom.sole or prevailing symptom.
Benign paroxysmal vertigo of childhood.Benign paroxysmal vertigo of childhood.
Prevalence 7Prevalence 7--9% of pts in referral dizzy9% of pts in referral dizzyand migraine clinics.and migraine clinics.
Not recognized by the IHSNot recognized by the IHS
Diagnosis (proposed criteria)Diagnosis (proposed criteria) – – Recurrent episodic vestibular symptoms of Recurrent episodic vestibular symptoms of
at least moderate severity.at least moderate severity.
– – One of the following:One of the following: Current of previous history of IHS migraine.Current of previous history of IHS migraine.
Migrainous symptoms during two or moreMigrainous symptoms during two or moreattacks of vertigo.attacks of vertigo.
MigraineMigraine--precipitants before vertigo in moreprecipitants before vertigo in more
than 50% of attacks.than 50% of attacks. – – Response to migraine medications in moreResponse to migraine medications in morethan 50% of attacksthan 50% of attacks
8/14/2019 Migraine 2
http://slidepdf.com/reader/full/migraine-2 10/23
Migraine mechanismMigraine mechanism
Neurovascular theory.Neurovascular theory.
– – Abnormal brainstem Abnormal brainstemresponses.responses.
– – TrigeminoTrigemino--vascular system.vascular system. Calcitonin gene relatedCalcitonin gene related
peptidepeptide
Neurokinin A Neurokinin A
Substance PSubstance P
Extracranial arterial vasodilation.Extracranial arterial vasodilation.
– – TemporalTemporal
– – Pulsing pain.Pulsing pain.
Extracranial neurogenicExtracranial neurogenicinflammation.inflammation.
Decreased inhibition of centralDecreased inhibition of centralpain transmission.pain transmission.
– – Endogenous opioids.Endogenous opioids.
8/14/2019 Migraine 2
http://slidepdf.com/reader/full/migraine-2 11/23
Important role inImportant role in
migrainemigraine
pathogenesis.pathogenesis. Mechanism of actionMechanism of action
in migraines not wellin migraines not well
established.established. Main target of Main target of
pharmacotherapy.pharmacotherapy.
8/14/2019 Migraine 2
http://slidepdf.com/reader/full/migraine-2 12/23
Aura Mechanism Aura Mechanism
Cortical spreading depressionCortical spreading depression
– – Self propagating wave of neuronal and glial depolarization acrosSelf propagating wave of neuronal and glial depolarization across thes thecortexcortex
Activates trigeminal afferents Activates trigeminal afferents – – Causes inflammation of pain sensitive meninges that generatesCauses inflammation of pain sensitive meninges that generates
HA through central/peripheral reflexes.HA through central/peripheral reflexes.
Alters blood Alters blood--brain barrier.brain barrier.
– – Associated with a low flow state in the dural sinuses. Associated with a low flow state in the dural sinuses.
8/14/2019 Migraine 2
http://slidepdf.com/reader/full/migraine-2 13/23
Auras Auras
– – Vision Vision – – most commonmost common
neurologic symptomneurologic symptom
– – ParesthesiaParesthesia of lips, lowerof lips, lower
face and fingers… 2face and fingers… 2ndnd
mostmostcommoncommon
– – Typical auraTypical aura
Flickering uncoloredFlickering uncolored
zigzag line in center andzigzag line in center andthen peripherythen periphery
MotorMotor – – hand and arm onhand and arm on
one sideone side
Auras (visual, sensory, Auras (visual, sensory,aphasia)aphasia) – – 1 hr1 hr
ProdromeProdrome
– – Lasts hours to days…Lasts hours to days…
8/14/2019 Migraine 2
http://slidepdf.com/reader/full/migraine-2 14/23
Clinical manifestationsClinical manifestations
Clinical manifestationsClinical manifestations
– – Lateralized in severe attacksLateralized in severe attacks – –6060--70%70%
– – Bifrontal/global HA Bifrontal/global HA – – 30%30%
– – Gradual onset with crescendoGradual onset with crescendopattern.pattern.
– – Limits activity due to itsLimits activity due to itsintensity.intensity.
– – Worsened by rapid headWorsened by rapid headmotion, sneezing, straining,motion, sneezing, straining,constant motion or exertion.constant motion or exertion.
– – Focal facial pain, cutaneousFocal facial pain, cutaneousallodynia, GI dysfunction,allodynia, GI dysfunction,facial flushing, lacrimation,facial flushing, lacrimation,rhinorrhea, nasal congestionrhinorrhea, nasal congestionand vertigo…and vertigo…
8/14/2019 Migraine 2
http://slidepdf.com/reader/full/migraine-2 15/23
Precipitating factorsPrecipitating factors
stressstress
head and neck infectionhead and neck infection
head trauma/surgeryhead trauma/surgery
aged cheeseaged cheese
dairydairy
red winered wine
nutsnutsshellfishshellfish
caffeine withdrawalcaffeine withdrawal
vasodilatorsvasodilators
perfumes/strong odorsperfumes/strong odorsirregular diet/sleepirregular diet/sleep
lightlight
8/14/2019 Migraine 2
http://slidepdf.com/reader/full/migraine-2 16/23
TreatmentTreatment
Abortive Abortive
– – SteppedStepped – – StratifiedStratified
– – StagedStaged PreventivePreventive
8/14/2019 Migraine 2
http://slidepdf.com/reader/full/migraine-2 17/23
Abortive Therapy Abortive Therapy
Reduces headache recurrence.Reduces headache recurrence.
Alleviation of symptoms. Alleviation of symptoms.
Analgesics Analgesics – – Tylenol, opioids…Tylenol, opioids…
Antiphlogistics Antiphlogistics
– –
NSAIDsNSAIDs
Vasoconstrictors Vasoconstrictors – – CaffeineCaffeine
– – SympathomimeticsSympathomimetics
– – SerotoninergicsSerotoninergics SelectiveSelective -- triptanstriptans
NonselectiveNonselective – – ergotsergots
MetoclopramideMetoclopramide
8/14/2019 Migraine 2
http://slidepdf.com/reader/full/migraine-2 18/23
Abortive care strategies Abortive care strategies SteppedStepped
– – Start with lower level drugs, then switch to more specific drugsStart with lower level drugs, then switch to more specific drugsif symptoms persist or worsen.if symptoms persist or worsen. Analgesics Analgesics – – Tylenol, NSAIDs…Tylenol, NSAIDs…
Vasoconstrictors Vasoconstrictors – – sympathomimetics…sympathomimetics…
Opioids (try to avoid)Opioids (try to avoid) -- ButorphanolButorphanol
TriptansTriptans – – sumatriptan (oral, SQ, nasal), naratriptan, rizatripatan,sumatriptan (oral, SQ, nasal), naratriptan, rizatripatan,zomatriptan.zomatriptan.
– – Limited by patient compliance.Limited by patient compliance.
StratifiedStratified – – Adjusts treatment according to symptom intensity. Adjusts treatment according to symptom intensity. MildMild – – analgesics, NSAIDsanalgesics, NSAIDs
ModerateModerate – – analgesic plus caffeine/sympathomimeticanalgesic plus caffeine/sympathomimetic
SevereSevere – – opioids, triptans, ergots…opioids, triptans, ergots…
– – Severe sx treatment limited due to concomitant GI sx’s.Severe sx treatment limited due to concomitant GI sx’s. StagedStaged
– – Bases treatment on intensity and time of attacks.Bases treatment on intensity and time of attacks.
– – HA diary reviewed with patient.HA diary reviewed with patient.
– – Medication plan and backup plans.Medication plan and backup plans.
8/14/2019 Migraine 2
http://slidepdf.com/reader/full/migraine-2 19/23
Preventive therapyPreventive therapy
Consider if pt has more than 3Consider if pt has more than 3--44episodes/month.episodes/month.
Reduces frequency by 40Reduces frequency by 40 – – 60%.60%.
Breakthrough headaches easier to abort.Breakthrough headaches easier to abort.
Beta blockersBeta blockers Amitriptyline Amitriptyline
Calcium channel blockersCalcium channel blockers
Lifestyle modification.Lifestyle modification.
Biofeedback.Biofeedback.
8/14/2019 Migraine 2
http://slidepdf.com/reader/full/migraine-2 20/23
BotoxBotox
51% migraineurs treated51% migraineurs treated
had complete prophylaxishad complete prophylaxis
for 4.1 months.for 4.1 months.
38% had prophylaxis for 2.738% had prophylaxis for 2.7
months.months.
Randomized trial showedRandomized trial showed
significant improvementsignificant improvement
in headache frequencyin headache frequency
with multiple treatments.with multiple treatments.
8/14/2019 Migraine 2
http://slidepdf.com/reader/full/migraine-2 21/23
ConclusionsConclusions
Migraine is common but unrecognized.Migraine is common but unrecognized.
Keep migraine and its variants in theKeep migraine and its variants in thedifferential diagnosis.differential diagnosis.
8/14/2019 Migraine 2
http://slidepdf.com/reader/full/migraine-2 22/23
8/14/2019 Migraine 2
http://slidepdf.com/reader/full/migraine-2 23/23